HUTCHMED (China)

HCMNasdaq Hong Kong Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.526 B

$14.48 +5.92%

Close of 21 Sept 2026

Revenue

$548.5M

#1862 by revenue

Earnings

$456.9M

#651 by earnings

Shares outstanding

872,327,620

Latest filing cover page

P/E ratio

5.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#84Disc MedicineIRON$2.63B
#85Structure TherapeuticsGPCR$2.62B
#86HUTCHMED (China)HCM$2.53B
#87PharvarisPHVS$2.51B
#88Mineralys TherapeuticsMLYS$2.50B

What if HUTCHMED (China) were worth as much as…

Open the what-if tool →

Gold $30.3T

$173,524.56

Per share 11,984× higher

Bitcoin $1.72T

$9,857.56

Per share 681× higher

Nvidia $5.48T

$31,409.40

Per share 2,169× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for HUTCHMED (China) are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.